RTW Investments, LP 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 06:15 am Sale |
2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 0 0.000% |
-5,469,956 (Position Closed) |
Filing |
| 2024-02-14 07:53 am Purchase |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 5,469,956 8.800% |
476,677 (+9.55%) |
Filing |
| 2023-02-14 10:04 am Purchase |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 4,993,279 9.600% |
1,126,407 (+29.13%) |
Filing |
| 2022-02-14 08:22 am Purchase |
2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 3,866,872 9.500% |
1,795,463 (+86.68%) |
Filing |
| 2021-02-12 10:12 am Unchanged |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 2,071,409 7.540% |
0 (Unchanged) |
Filing |
| 2020-11-13 09:57 am Purchase |
2020-11-03 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 2,071,409 7.550% |
2,071,409 (New Position) |
Filing |